Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Metagenomes from Winam Gulf, Lake Victoria (2022-2023), Lake Simbi (2022-2023), and Lake Naivasha (2022)

PROVIDER: PRJNA1119566 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR29270200_1.fastq.gz	Fastqsanger.gz
	SRR29270200_2.fastq.gz	Fastqsanger.gz
	SRR29270201_1.fastq.gz	Fastqsanger.gz
	SRR29270201_2.fastq.gz	Fastqsanger.gz
	SRR29270202_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 96

Similar Datasets

laser-captured chondrocyte transcriptomes from cranial base

Project description:similar methods as in Gomez-Picos et al. (2022) and Nguyen et al. (2023)

2023-12-18 | GSE249932 | GEO

Diel cycles of gene expression in oligotrophic, dystrophic, and eutrophic lakes to identify new gene functions and dissect carbon cycling metabolisms

Project description:Aquatic microbial communities contain a vast amount of genetic diversity and we have much to learn about how this manifests to functional diversity. Existing long-term time series data includes 16S tags, metagenomes, single amplified genomes (SAGs), and genomes from metagenomes (GFMs). Information about functional diversity and metabolic capabilities is often unavailable. The study sites include three lakes that are the subject of intense study through the North Temperate Lakes Long Term Ecological Research site: Sparkling Lake (oligotrophic), Lake Mendota (eutrophic), and Trout Bog Lake (dystrophic). The work (proposal:https://doi.org/10.46936/10.25585/60000947) conducted by the U.S. Department of Energy Joint Genome Institute (https://ror.org/04xm1d337), a DOE Office of Science User Facility, is supported by the Office of Science of the U.S. Department of Energy operated under Contract No. DE-AC02-05CH11231.

2023-11-02 | MSV000093272 | MassIVE

freshwater metagenome

Project description:Lake Victoria cyanobacteria

| PRJNA996591 | ENA

Diphtheria The Netherlands

Project description:Diphtheria The Netherlands 2022-2023

| PRJEB80212 | ENA

Project description:2022/2023 Malawi Cholera Outbreak

| PRJNA967700 | ENA

Psychrotolerant bacterium Sphingomonas glacialis AAP5 harvests light energy using both proton-pumping xanthorhodopsins and bacteriochlorophyll-based reaction centers

Project description:Bacterium Sphingomonas glacialis AAP5 isolated from the alpine lake Gossenköllesee contains genes for anoxygenic phototrophy as well as proton-pumping xanthorhodopsin. Here we show that AAP5 expresses xanthorhodopsin when illuminated at temperatures below 16°C. In contrast bacteriochlorophyll-containing reaction centers are expressed between 4 and 22°C in the dark. Thus, cells grown at lower temperature under natural light-dark cycle produced both photosystems. The purified xanthorhodopsin contains carotenoid nostoxanthin serving as an auxiliary antenna and performs the standard photocycle. The xanthorhodopsin-containing cells reduced upon illumination their respiration, increased their ATP synthesis and produced more biomass. This documents that the harvested light energy was utilized in the metabolism, which can represent a competitive advance under carbon-limiting conditions. The presence of Sphingomonas bacteria with dual phototrophy was verified in the metagenomes collected from lake Gossenköllesee. This unique trait may represent a metabolic advantage in alpine lakes where photoheterotrophic organisms facelimited organic substrates, low temperature, and extreme changes in irradiance.

2022-05-10 | GSE196609 | GEO

Features of chronic urticaria after COVID-19 mRNA vaccine, a real-life cohort study

Project description:New onsets of chronic urticaria (CU) have been reported after repeated immunizations, mainly with the Moderna mRNA-1273 vaccine (Spikevax). This study aims to evaluate patients with CU after COVID-19 mRNA vaccination. The contribution of SARS-Cov2 infection, atopy and IgE against the vaccine was analyzed. We monitored the features of patients who developed CU after vaccination in the Canton of Vaud through two surveys conducted in 2022 and 2023. Fifty individuals with CU underwent blood tests, and their results were compared with individuals without a history of urticaria (N=135). The presence of anti-vaccine IgE was detected with basophil activation tests (BAT). We assessed anti-SARS-Cov2 humoral response, and the presence of IgEs against common respiratory allergens (Phadiatop) as a surrogate for atopy. Post-vaccination CU occurred after a median interval of 10 days and significantly more after the Spikevax booster, affecting middle-aged individuals (median 41, 66% females). In 2023, CU was still active in 53% of the cases. Inducible forms of CU, primarily dermographism, were reported in 54% (2022) and 61% (2023) of the cases. BAT positivity was not specific to CU, anti-nucleocapsid positivity, or atopy but was significantly associated with higher anti-spike neutralizing activities and younger age. Four CU patients tolerated an additional dose of mRNA vaccine with no disease exacerbation/recurrence. The spikevax booster induced anti-vaccine IgE independently of CU, the latter being not directly associated with COVID-19 infection nor atopy. The tolerance to a new booster in 4/4 patients suggests that the Spikevax vaccine indirectly triggered CU in predisposed individuals.

2024-07-26 | GSE272645 | GEO

Streptococcus pneumoniae

Project description:Streptococcus pneumoniae isolated during 2022-2023

| PRJNA1045333 | ENA

plankton metagenome

Project description:FATO sediment trap (2022-2023) analysis

| PRJDB18587 | ENA

Influenza season 2022-2023 Oxford sequencing

Project description:Influenza season 2022-2023 Oxford sequencing

| PRJEB56915 | ENA